151 related articles for article (PubMed ID: 9857238)
1. Possible prediction of adverse reactions to fluorouracil by the measurement of urinary dihydrothymine and thymine.
Sumi S; Kidouchi K; Kondou M; Hayashi K; Dobashi K; Kouwaki M; Togari H; Wada Y
Int J Mol Med; 1998 Oct; 2(4):477-82. PubMed ID: 9857238
[TBL] [Abstract][Full Text] [Related]
2. Population and family studies of dihydropyrimidinuria: prevalence, inheritance mode, and risk of fluorouracil toxicity.
Sumi S; Imaeda M; Kidouchi K; Ohba S; Hamajima N; Kodama K; Togari H; Wada Y
Am J Med Genet; 1998 Jul; 78(4):336-40. PubMed ID: 9714435
[TBL] [Abstract][Full Text] [Related]
3. Possible prediction of adverse reactions to pyrimidine chemotherapy from urinary pyrimidine levels and a case of asymptomatic adult dihydropyrimidinuria.
Hayashi K; Kidouchi K; Sumi S; Mizokami M; Orito E; Kumada K; Ueda R; Wada Y
Clin Cancer Res; 1996 Dec; 2(12):1937-41. PubMed ID: 9816152
[TBL] [Abstract][Full Text] [Related]
4. [A case of gastric cancer with decreased dihydropyrimidine dehydrogenase activity].
Kobayashi K; Sumi S; Kidouchi K; Mizuno I; Mohri N; Fukui T; Akamo Y; Takeyama H; Manabe T
Gan To Kagaku Ryoho; 1998 Jul; 25(8):1217-9. PubMed ID: 9679586
[TBL] [Abstract][Full Text] [Related]
5. Preliminary Evidence for Enhanced Thymine Absorption: A Putative New Phenotype Associated With Fluoropyrimidine Toxicity in Cancer Patients.
Duley JA; Ni M; Shannon C; Norris RL; Sheffield L; Cowley D; Harris M; van Kuilenburg ABP; Helsby N; George R; Charles BG
Ther Drug Monit; 2018 Aug; 40(4):495-502. PubMed ID: 29846282
[TBL] [Abstract][Full Text] [Related]
6. Dihydropyrimidine dehydrogenase deficiency presenting at birth.
Al-Sanna'a NA; Van Kuilenburg AB; Atrak TM; Abdul-Jabbar MA; Van Gennip AH
J Inherit Metab Dis; 2005; 28(5):793-6. PubMed ID: 16151913
[TBL] [Abstract][Full Text] [Related]
7. Dihydropyrimidine dehydrogenase deficiency leading to thymine-uraciluria. An inborn error of pyrimidine metabolism.
Berger R; Stoker-de Vries SA; Wadman SK; Duran M; Beemer FA; de Bree PK; Weits-Binnerts JJ; Penders TJ; van der Woude JK
Clin Chim Acta; 1984 Aug; 141(2-3):227-34. PubMed ID: 6488556
[TBL] [Abstract][Full Text] [Related]
8. Quantification of uracil, dihydrouracil, thymine and dihydrothymine for reliable dihydropyrimidine dehydrogenase (DPD) phenotyping critically depend on blood and plasma storage conditions.
van den Wildenberg SAH; Streng AS; van den Broek R; Broeren MAC; Deenen MJ; van Dongen JLJ; Hanrath MA; Lapré C; Brunsveld L; Scharnhorst V; van de Kerkhof D
J Pharm Biomed Anal; 2022 Nov; 221():115027. PubMed ID: 36099723
[TBL] [Abstract][Full Text] [Related]
9. [Review of methods for determination of dihydropyrimidine dehydrogenase and possible application in screening previous chemotheraphy with 5-fluorouracil].
Ostapowicz A; Dołegowska B
Przegl Lek; 2012; 69(9):694-7. PubMed ID: 23401991
[TBL] [Abstract][Full Text] [Related]
10. [Dihydropyrimidine déhydrogenase (DPD) deficiency screening and securing of fluoropyrimidine-based chemotherapies: Update and recommendations of the French GPCO-Unicancer and RNPGx networks].
Loriot MA; Ciccolini J; Thomas F; Barin-Le-Guellec C; Royer B; Milano G; Picard N; Becquemont L; Verstuyft C; Narjoz C; Schmitt A; Bobin-Dubigeon C; Harle A; Paci A; Poinsignon V; Quaranta S; Evrard A; Hennart B; Broly F; Fonrose X; Lafay-Chebassier C; Wozny AS; Masskouri F; Boyer JC; Etienne-Grimaldi MC
Bull Cancer; 2018 Apr; 105(4):397-407. PubMed ID: 29486921
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of dihydropyrimidine dehydrogenase deficiency in a neonate with thymine-uraciluria.
Au KM; Lai CK; Yuen YP; Shek CC; Lam CW; Chan AY
Hong Kong Med J; 2003 Apr; 9(2):130-2. PubMed ID: 12668826
[TBL] [Abstract][Full Text] [Related]
12. Development and characterization of a monoclonal antibody with cross-reactivity towards uracil and thymine, and its potential use in screening patients treated with 5-fluorouracil for possible risks.
Honda T; Inagawa H; Fukushima M; Moriyama A; Soma G
Clin Chim Acta; 2002 Aug; 322(1-2):59-66. PubMed ID: 12104082
[TBL] [Abstract][Full Text] [Related]
13. Dihydropyrimidine dehydrogenase deficiency: a pharmacogenetic defect causing severe adverse reactions to 5-fluorouracil-based chemotherapy.
Morrison GB; Bastian A; Dela Rosa T; Diasio RB; Takimoto CH
Oncol Nurs Forum; 1997; 24(1):83-8. PubMed ID: 9007910
[TBL] [Abstract][Full Text] [Related]
14. Lack of correlation between phenotype and genotype for the polymorphically expressed dihydropyrimidine dehydrogenase in a family of Pakistani origin.
Fernandez-Salguero PM; Sapone A; Wei X; Holt JR; Jones S; Idle JR; Gonzalez FJ
Pharmacogenetics; 1997 Apr; 7(2):161-3. PubMed ID: 9170156
[TBL] [Abstract][Full Text] [Related]
15. Towards a test to predict 5-fluorouracil toxicity: Pharmacokinetic data for thymine and two sequential metabolites following oral thymine administration to healthy adult males.
Duley JA; Ni M; Shannon C; Norris RL; Sheffield L; Harris M; van Kuilenburg AB; Mead S; Cameron A; Helsby N; George R; Charles BG
Eur J Pharm Sci; 2016 Jan; 81():36-41. PubMed ID: 26435217
[TBL] [Abstract][Full Text] [Related]
16. 5-FU-induced neurotoxicity in cancer patients with profound DPD deficiency syndrome: a report of two cases.
Cordier PY; Nau A; Ciccolini J; Oliver M; Mercier C; Lacarelle B; Peytel E
Cancer Chemother Pharmacol; 2011 Sep; 68(3):823-6. PubMed ID: 21553285
[TBL] [Abstract][Full Text] [Related]
17. New insights in dihydropyrimidine dehydrogenase deficiency: a pivotal role for beta-aminoisobutyric acid?
Van Kuilenburg AB; Stroomer AE; Van Lenthe H; Abeling NG; Van Gennip AH
Biochem J; 2004 Apr; 379(Pt 1):119-24. PubMed ID: 14705962
[TBL] [Abstract][Full Text] [Related]
18. Prevention of 5-fluorouracil-induced early severe toxicity by pre-therapeutic dihydropyrimidine dehydrogenase deficiency screening: Assessment of a multiparametric approach.
Boisdron-Celle M; Capitain O; Faroux R; Borg C; Metges JP; Galais MP; Kaassis M; Bennouna J; Bouhier-Leporrier K; Francois E; Baumgaertner I; Guerin-Meyer V; Cojocarasu O; Roemer-Becuwe C; Stampfli C; Rosenfeld L; Lecompte T; Berger V; Morel A; Gamelin E
Semin Oncol; 2017 Feb; 44(1):13-23. PubMed ID: 28395758
[TBL] [Abstract][Full Text] [Related]
19. Screening and diagnosis of beta-ureidopropionase deficiency by gas chromatographic/mass spectrometric analysis of urine.
Ohse M; Matsuo M; Ishida A; Kuhara T
J Mass Spectrom; 2002 Sep; 37(9):954-62. PubMed ID: 12271438
[TBL] [Abstract][Full Text] [Related]
20. [Dihydropyrimidine dehydrogenase activity and its genetic aberrations].
Ogura K
Gan To Kagaku Ryoho; 2006 Aug; 33(8):1041-8. PubMed ID: 16912518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
